ISPUB.com / IJEICM/12/1/7091
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Emergency and Intensive Care Medicine
  • Volume 12
  • Number 1

Original Article

Urban Inner-City Minority New Yorkers Hospitalized With Novel Swine-Origin Influenza A H1N1 Virus Illness During The Pandemic Of April – June 2009

R Loganathan, Y Sitnitskaya, M Schori, A Saeed, F Rivera, J Bastos, Y Carreras, B Kanna

Keywords

community health, disparities, minorities, outcomes, pulmonary diseases

Citation

R Loganathan, Y Sitnitskaya, M Schori, A Saeed, F Rivera, J Bastos, Y Carreras, B Kanna. Urban Inner-City Minority New Yorkers Hospitalized With Novel Swine-Origin Influenza A H1N1 Virus Illness During The Pandemic Of April – June 2009. The Internet Journal of Emergency and Intensive Care Medicine. 2009 Volume 12 Number 1.

Abstract


Background:
New York City (NYC) was an epicenter in 2009 of a novel SOIV illness outbreak in the US. Due to barriers to early care and prevalence of health risks, severity among urban inner-city minority patients is greater. Disparities of severity and outcomes have been described based on age and co-morbidity. We report the 2009 SOIV illness characteristics and comparison between young and older urban minority New Yorkers during the 2009 pandemic. Methods:
A retrospective study of SOIV-illness among inner-city minority New Yorkers hospitalized in a city-hospital setting at South Bronx was conducted. Two hundred and ninety eight individuals had a positive screening rapid influenza antigen diagnostic (RIDT) test. Among them, 40 adults (> 18 years age) and 40 children were hospitalized with SOIV illness. Results: All study patients were urban New Yorkers of Hispanic (75%) or African American background (25%). Fourteen tested RIDT +, 5 had polymerase chain reaction (PCR) + and 61 had both positive. Adult’s SOIV illness were mostly young (median age 44.5 years), but among children there was no age predilection. Frequent co-morbidities (75% in adults & 47.5% in children) such as chronic airway disease, diabetes and obesity were noted. Adults requiring intensive care (37.5%) had higher prevalence of diabetes, were severely ill on admission ( median SOFA & APACHE-II scores 13 & 31 respectively), had greater length of stay (median 6 days) and significant mortality (26.6 %). Only adults had organ dysfunction (42.5%). About 10% of adults died who mostly were young and obese. Compared to adults, children had less severe SOIV illness not associated with death, intensive care admission or organ dysfunction. Conclusion:
This is the first detailed study of hospitalized pediatric and adult New Yorkers highlighting age-related health disparities due to 2009 SOIV illness among urban inner-city ethnic minority. In order to provide early and effective care to SOIV-infected inner-city patients and optimize outcomes, health-care providers should be aware of clinical risks and differences in disease characteristics within this population.

 

Introduction

Infection due to 2009 novel swine origin Influenza-A H1N1 virus (SOIV) has emerged as a global pandemic (1). In the United States (US) and worldwide, several case series of severe disease and deaths have been reported. (2-9). In the US, New York City (NYC) was the first epicenter of the SOIV illness outbreak (4). US surveillance data reveals that 6.9% of all deaths were due to influenza and pneumonia, higher than the epidemic threshold of 6.6% (10). Currently, there are no studies on differences among characteristics of hospitalized SOIV infected inner-city minority adult and pediatric patients, except for a recent report on SOIV features among New Yorkers (4). Lincoln Medical and Mental Health center (LMMHC), a university-affiliated urban public NYC Health and Hospital Corporation institution serving inner-city minority New Yorkers in the South Bronx, encountered a number of cases with Influenza-Like Illness (ILI) during the 2009 outbreak. The characteristics and comparison of hospitalized pediatric and adult with SOIV illness are reported.

Methods and Materials

A retrospective observational study was conducted on adult and pediatric patients hospitalized for at least 24 hours with ILI and laboratory evidence of “probable” or “confirmed” 2009 SOIV-illness to LMMHC between April-July 2009. The study protocol and data abstraction tools were approved by the Institutional Review Board and informed consent was waived.

Patients with ILI were identified through daily reports from the emergency department(ED) and hospital wards. Data on demographic features, co-morbidity, clinical characteristics, laboratory tests and outcomes were extracted by 2 trained independent investigators using a standardized data-collection tool. Data regarding ED visits including respiratory infections utilizing ICD-9 codes were also collected.

Children were admitted to either pediatric ward or 8-bed pediatric intensive care unit (PICU) staffed 24/7 by on-call American board certified pediatricians and intensivists. Adult critically-ill patients were admitted to a closed medical ICU (MICU) staffed 24/7 by board certified critical care specialists. Standard ICU protocols were utilized in management of all patients. In medical ICU patients, length of stay, organ dysfunction, mechanical ventilation, Acute Physiology and Chronic Health Evaluation (APACHE) -II scores, and Sequential Organ Failure Assessment (SOFA) score on admission were noted. Organ dysfunction was defined using variables from the SOFA-scoring system with 0 being the best possible and 24 being the worst (11).

Microbiological specimens were obtained using either a naso-pharyngeal swab or bronchial aspirate after endotracheal intubation in mechanically ventilated patients. Testing for influenza viruses was performed by a RIDT that detects influenza viral nucleoprotein antigen. This assay distinguishes influenza A/B viruses but not between influenza A subtypes. Positive RIDT results and selected patients with ILI with high suspicion and negative RIDT results were tested for influenza virus subtypes subsequently using Reverse Transcriptase- Polymerase chain reaction (RT-PCR) performed at the NYC Department of Health Public Health Laboratory.

ILI was defined as fever (temperature of 100°F [37.8°C] or greater) and cough and/or sore throat in the absence of a known cause other than influenza. A “confirmed” case of SOIV-illness was defined as a patient with an ILI and laboratory confirmed SOIV illness by RT-PCR. A “probable” case of SOIV illness is defined as a person with ILI, positive rapid antigen test for influenza-A, but did not have or tested negative by RT-PCR. Obesity was defined as a body mass index (BMI) of > 30 kg/m2, or a BMI percentile of =/> 95 in children between the ages of 2 and 18 years, while overweight adults included those with BMI between 25-29 kg/m2.

Statistical Methods

Descriptive data for adult and pediatric patients are presented separately and compared. Statistical analysis was performed using the Fischer’s exact test for categorical variables and Mann Whitney U test for continuous variables. A p value of < 0.05 was considered significant. Data was analyzed using STATA-version 8.0. The investigator analyzing the data was blinded to medical records.

Results

From April-July 2009, there were 55862 ED visits at LMMHC, with more than 16000 visits in May 2009 and 14000 in June 2009. About 12000 to 13000 patients were treated in the LMMHC ED every month in the last 2-year-period. The average number of ED visits during the pandemic increased to 13965 per month compared to an average of 12464 per month within the past 2 years, an increase of 12% every month (Figure-1).

A total of 2072 ED visits were related to a respiratory infection based on ICD-9 codes, which is a 25% increase in average number of visits related to respiratory infection during the 4-month study period (518 versus 416 visits). 1884 patients had ILI and underwent a RIDT. Of these, 298 were RIDT positive of which 80 patients including 40 adults and 40 children were hospitalized with confirmed or probable SOIV-illness. (Figure 2) Of the 40 adults, 35 were confirmed and 5 probable cases of SOIV-illness. In children, there were 39 confirmed and 1 probable cases. Among all, 14 tested RIDT positive, 5 had RT-PCR positive and 61 had both tests positive (Table-1).

SOIV-illness in minority adults

Clinical data, laboratory features, treatment and outcomes among adults are shown in Tables-2a & 2b. 77% of adults were Hispanic and 23%, African Americans. Thirty (75%) adults had one co-morbidity mainly overweight/obesity, 15 (37.5%) were admitted to MICU and 4 (10%) died during hospitalization. Median hospital length of stay among adults was 4.5 days (range: 01-62 days).

In the evaluation of obesity in SOIV-illness among our subjects, 60% (26) were overweight or obese, and 27% (11) had BMI > 30 kg/m2 in which is in concordance with the 25% obesity prevalence(26, 29) within the South Bronx (p=NS). Four obese adults required ICU care (p= 0.162) and of whom 3 died (p=0.056).

Fifteen of 40 adults (37.5%) required admission to MICU. Median age of MICU patients was 52 (range 22-79 years), and 5 patients were older than 65 years. Thirteen (87%) patients had at least one co-morbid condition, namely asthma/COPD (07), heart disease (04), diabetes mellitus (08) and Overweight/obesity (09) (median BMI of 33.5 kg/m2). Median admission APACHE-II score was 31 with a median admission SOFA score of 13. Ten (67%) had lymphopenia, 7 (47%) had elevated serum-CPK (median, 563 u/L) and another 7 (47%) had high serum-LDH values (median, 362 u/L). On chest radiographs, the following were noted: normal (04), alveolar consolidation (07), interstitial infiltrates (02) and nodular infiltrates (02). Interestingly, only 3 MICU patients tested positive for influenza-A antigen RIDT on the nasopharyngeal (NP) swab while the remaining 12 tested positive RIDT from bronchial washings or tracheal aspirates. RT-PCR was tested in 8 of the 15 patients and 6 were positive. Fourteen (93. 3%) patients developed respiratory failure, 10 (66.6%) had severe sepsis or septic shock and a similar number had acute kidney injury. Thirteen (86.7%) adults required non-invasive or mechanical ventilation support. Adults in MICU compared to other adults were noted to have higher proportion of diabetes (53% vs.16%, p=0.03), median serum-LDH (317 vs.170 u/L, p=0.043) and abnormal chest radiographs (80% vs.36%, p =0.01) (Table 2b). The median MICU length of stay (LOS) was 6 days while the hospital-LOS for MICU patients 15 days.

In-hospital observed mortality for ICU patients was 26.6% (4/15). Among patients who died, all had at least one co-morbid condition (p=NS), 4 had tachycardia and abnormal chest X-rays (p=NS), 3 presented with tachypnea (p<0.05), high serum-CPK and LDH levels (p=NS).

SOIV-illness in minority children

Clinical data, laboratory features, treatment and outcomes in children are shown in Tables-3a & 3b. 72% of the children were Hispanic and 28%, African-Americans. Although about half of them had co-morbidity, there were no deaths or organ dysfunction among children. 11(27.5%) of 40 children were observed in pediatric ICU, 4 of whom had sickle cell disease (p = 0.004), 2 had asthma and 2 were overweight/obese (p=NS). Median hospital-LOS among children and adolescents was 3 days on the ward and 4 days in the PICU.

When children of different age groups (< 4, 5 to 12 yrs, and 12 to 18 yrs) were compared, the youngest had less co-morbidity, lymphopenia and abnormal chest radiographic findings. (Table-3b) Three children (7.5%) between 0-4 years of age developed otitis media.

Comparing adults and children with SOIV-illness

Compared to children, adults had higher proportion of subjects with co-morbidity (75% vs.42.5%, p=0.039); organ failure (42.5% vs.0%, p-value=0.000); mechanical ventilation support (32.5% vs. 0%, p-value =0.000); median LOS (4.5 vs.3 days, p=0.0011) and deaths (10% vs.0%, p-value = 0.116).

Figure 1
Figure 1: LMMHC ED visits from Sept 07 to Aug 09

Figure 2
Figure 2: Patient selection

Figure 3
Table 1: SOIV illness test results

Figure 4
Table 2a: Clinical Characteristics of adults with probable or confirmed SOIV Illness

Figure 5
Table-2b: Clinical features Of Adult ICU Patients compared to Adult non-ICU patients with SOIV Illness

Figure 6
Table 3a: Demographic and Clinical features of children with probable or confirmed SOIV Illness

Figure 7
**Table 3b: Selected clinical characteristics across pediatric age groups

Discussion

This is the first study to describe separately and compare hospitalized adult and pediatric subjects during the 2009 SOIV-illness outbreak among urban inner-city residents of NYC. The ethnic distribution of our study subjects followed the population distribution of predominantly Hispanic and African-Americans in the South-Bronx (12). All of our study subjects were from the South Bronx zip-codes constituting the primary and secondary services areas of LMMHC. All children and 95% of adults had health insurance. Lack of insurance and access to care therefore does not seem to be a barrier in this study population. Adults at our institution had higher morbidity and mortality than children, a finding not seen in other reports (2-9).

Compared to seasonal-influenza13, adults hospitalized at our institution with SOIV illness were of younger age (median: 48 years), frequently had chronic illness (72.5%), and often had severe illness that required critical care, similar to other recent reports (7-10). Gastrointestinal (GI) symptoms of vomiting, abdominal pain and diarrhea were noted at presentation among a higher proportion of adults (32.5%). 2/3rd of our adult patients were overweight/obese (65%) which is not a known risk factor for seasonal influenza. A higher but statistically non-significant proportion of obese individuals versus non-obese (29.7% vs.12.7%, p=NS) and overweight/obese combined versus non-obese/overweight adults (38.5% vs. 21.4%, p=NS), required invasive or non-invasive ventilation support, concurring with recent reports of severe illness among previously healthy obese subjects (15). Obese patients are likely to have decreased respiratory reserve or pre-existing lung conditions like obesity-hypoventilation syndrome. It is postulated that obesity may lead to altered immune function that leads to a decreased response to influenza viruses (14), although it is unclear why the 2009 SOIV afflicts obese subjects more. These factors combined with severe respiratory illness may explain the requirement for mechanical ventilation and MICU care among our SOIV-infected minority adult patients.

Our adult-MICU patients had relatively severe illness (median-SOFA score on admission 13 and APACHE-II score=31) compared with other reports on utilization of critical care resources for SOIV-illness (7-10). Many of them had severe-sepsis and required mechanical ventilation. Adult-MICU patients (53%) compared to non-ICU adult patients (16%) had a higher proportion of diabetes, but not obesity. Thrombocytopenia, abnormal CPK, and LDH elevations were noted frequently in MICU cases. Lymphopenia was present in 3/4th of adult patients (<1000 cells/mm3) as reported in recent studies in the US and Mexico (6, 8, 9). Although adult-MICU cases had significantly more abnormal chest X-rays than non-MICU cases, 4 of the 15 MICU cases had normal chest-X ray on presentation. A unique feature noted among critically-ill adults was the poor reliability of RIDTs with naso-pharyngeal swabs (3/15 positive) compared to lower respiratory-tract specimens (12/15 positive). 2/3rd of adults including all MICU-patients received anti-bacterial antibiotics at admission whereas only 2 patients had a confirmed isolate on cultures. Oseltamivir (Tamiflu) at standard recommended dose and frequency was initiated in all except 1 adult on the day of admission (16). 55% of adults and 30% of children presented with abnormal chest radiographs. Focal consolidation rather than an interstitial pattern of involvement in seasonal influenza was the most common type of radiological involvement in SOIV-illness. These findings could represent secondary or superimposed bacterial pneumonia that may be indistinguishable from the primary viral pneumonia previously described with the seasonal influenza (17, 18). Corticosteroids were administered to patients with obstructive lung disease exacerbations (25%) and those with critical illness related corticosteroid insufficiency (CIRCI, 22.5%). The overall mortality rate among hospitalized adults was 10%. Median age of adults who died was 46.5 years (range 30-55years), many of them were obese, a finding not seen in seasonal influenza. The observed mortality among adult-ICU patients was 26 %, similar to reports from Mexico and Canada (8, 9, and 19).

Among children, GI symptoms were seen in a similar proportion (30%) as in patients with seasonal influenza, but less than among children in a national cohort of SOIV illness (42%). (6) Wheezing occurred in 3/10 asthmatic children and only in 4 patients without asthma. Also, one-quarter of children > 2 years of age were obese, comparatively less than in pediatric patients from the national US cohort (30%). Lymphopenia was common and noted in approximately half of our children (mostly among those older than 4 years of age) compared to other reports (20). None of them had clinical myositis (21). No child had invasive bacterial co-infection, but 2/3rd of cases received systemic antibiotics. Although bacteriology cultures were less revealing, focal radiograph findings in our study and 2 recent reports on H1N1 illness demonstrating frequent concurrent bacterial infections in 29-43% of subjects underscore the importance of early recognition and treatment of bacterial infection on admission in SOIV illness (22). Abnormal chest radiographs were least common among youngest patients, while ½ of children > 5 years had abnormal chest x-rays, consolidation being the most common pattern as in adults. All children received Oseltamivir on day of admission and 9 pediatric patients received steroid therapy. Although 1/4th of children were treated at the pediatric-ICU under close monitoring, none had organ dysfunction, or required ventilation support. We did not observe any deaths among pediatric subjects and this is contrary to reports of significant case fatality among children (23). This can be related to several reasons. First, none of them had neuro-muscular disorder or immune suppression, the 2 factors associated with poor outcome in a recent report of pediatric deaths from SOIV illness (23). Secondly, none of them had invasive bacterial co-infection as reported in a recent autopsy study on mortality related to SOIV-illness (23).

According to CDC estimates, the baseline percentage of SOIV illness-related visits in the New York State region is 2.9% of all visits in 2009 (24). Based on the volume of patient visits at LMMHC-ED, the expected number of influenza case visits is 287 cases per month. During the 4 month period, compared to the 1148 expected cases based on CDC estimates, more (1884) patients with ILI were seen in our ED. The 12% rise in total ED visits during this period suggests that there could have been more non-tested cases of SOIV illness.

The main limitations of our study are the relatively limited sample size and lack of non-minority controls. However, our data represents the largest sample that any single center has reported in the literature on this new emerging infectious disease, especially among urban inner city populations. Despite lack of non-minority controls, we compared our data with current reports of H1N1 cases in other US and international populations (2-9) and also provided age-based control comparisons within our sample.

Our study highlights the unique risk factors, age-related and ethnic disparities related to SOIV-illness among inner-city minority New Yorkers. Given the characteristics of the minority population in inner-city areas with increased prevalence of co-morbid conditions including diabetes, obesity and asthma, compounded by the decreased access to medical care that may result in delayed presentation, population mixing and overcrowding, decreased vaccination rates, the risk for adverse outcomes due to SOIV illness in these populations may be greater (25, 26). In a busy urban inner-city hospital emergency room setting, patients at highest risk for severe SOIV-illness, should be promptly identified during triage and treatment established. Health care institutions serving urban inner-city populations may experience greater demand during pandemics related to excess volume of ED visits and increased need for hospitalization or critical care. Public health policy must consider and address the urban minority population risks and health care system preparedness in the national response to emerging pandemics and allocate appropriate resources.

Conclusion

In summary, SOIV-illness presents with unique clinical features among urban inner-city minority New-Yorkers. Our study found that morbidity and mortality due to SOIV-illness were greater among adults compared to children and associated with non-traditional risk factors such as obesity. Severity of illness and deaths were greater in young adults. The observed clinical features, morbidity and mortality among urban minority adult patients during the SOIV-pandemic are different from seasonal-influenza. A full understanding of this new emerging infection is essential to target those at risk for adverse outcomes, re-direct public health strategies and re-allocate resources to heath care institutions serving inner-city minority populations.

Acknowledgements

  • Raghu Loganathan MD FCCP : Writing research protocol, creating data abstraction tool, writing IRB protocol and obtaining approval, data abstraction and review, manuscript preparation and review

  • Yekaterina Sitnitskaya MD: Writing research protocol, creating data abstraction tool, presenting to IRB, data abstraction and review, manuscript preparation and review

  • Melissa Schori MD MBA : Conceptualization of study, Data collection, Manuscript preparation and review

  • Aliya Saeed MD: Data collection.

  • Felix Rivera MD: Manuscript preparation and review.

  • Jorge Bastos MD: Data collection.

  • Yuly Carreras MD: Data Collection.

  • Balavenkatesh Kanna MD, MPH, FACP : Writing the research protocol, Data compiling and review, manuscript preparation and review, statistical analysis

References

1. Pandemic (H1N1) 2009- Update 71: Geneva World Health Organization. Available at: http://www.who.int/csr/don/2009_10_23/en/index.html , Accessed November 11, 2009.
2. Swine influenza A (H1N1) infection in two children --- Southern California, March-April 2009. MMWR Wkly Rep 2009; 58:400-402. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0421a1.htm , Accessed November 11, 2009.
3. Hospitalized patients with novel influenza A (H1N1) virus infection --- California, April-May 2009. MMWR 2009;58:536-541
4. Patients Hospitalized with 2009 Pandemic Influenza A (H1N1) --- New York City, May 2009. MMWR Jan 08, 2010; 58(51&52);1436-1440
5. Update: Influenza Activity --- United States, April-August 2009. MMWR 2009; 58:1009-1012.
6. Jain S, Kamimoto J, Bramley A, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, N Engl J Med 2009; 361-70.
7. The ANZIC Influenza Investigators. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 2009; 361.
8. Chowell G, Bertozzi S, Arantxa-Colchero M. Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico. Rogelio Perez-Padilla. N Engl J Med 2009; 361:680-689.
9. Domínguez-Cherit G, Lapinsky S, Macias A. Critically Ill Patients with 2009 Influenza A (H1N1) in Mexico. JAMA 2009; 302:1880-1887.
10. U.S. Influenza and Pneumonia-Associated Hospitalizations and Deaths from August-October 2009. Available at: http://www.cdc.gov/h1n1flu/updates/us/ Accessed October 19, 2009.
11. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996 Jul;22(7):707-10.
12. Olson EC, Van Wye G, Kerker B et al. Take Care Highbridge and Morrisania. NYC Community Health Profiles, Second Edition; 2006; 6(42):1-16
13. Scott A. Harper, 1 John S. Bradley et al. Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases 2009; 48:1003–32.
14. Smith A, et al. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr. 2007; 137:1236-43.
15. Louie JK, Acosta M, Winter K et al. Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California. JAMA. 2009;302(17):1896-1902
16. CDC H1N1 flu - Information for Health Care Professionals. Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season.Available at: http://www.cdc.gov/H1N1flu/antivirals/ Accessed February 1, 2010.
17. Schwarzmann SW, Adler JL, Sullivan RFJ, et al: Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127:1037-1041.
18. Bisno AL, Griffin JP, VanEpps KA: Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic. Am J Med Sci 1971; 261: 251-274.
19. Kumar A; Ryan Zarychanski R; Ruxandra Pinto R et al. for the Canadian Critical Care Trials Group H1N1 Collaborative Critically Ill Patients with 2009 Influenza A (H1N1) Infection in Canada JAMA. 2009; 302(17):1872-1879.
20. Cunha BA, Pherez FM, Paul Schoch P. Diagnostic Importance of Relative Lymphopenia as a Marker of Swine Influenza (H1N1) in Adults. Clinical Infectious Diseases 2009; 49:1454–1456.
21. D'Silva D, Hewagama S, Doherty R. PIDJ. October 16, 2009; doi: 10.1097/INF.0b013e3181c03cf2. Available at: http://journals.lww.com/pidj/Abstract/publishahead/Melting_Muscles__Novel_H1N1_Influenza_A_Associated.99512.aspx , Accessed on December 12, 2009.
22. Bacterial Co-infections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) --- United States, May--August 2009. MMWR weekly October 2, 2009 / 58(38); 1071-1074.
23. Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection --- United States, April--August 2009. MMWR Weekly, September 4, 2009 / 58(34); 941-947
24. Influenza Activity, Surveillance and Reports. NYSDOH 2008-2009 Influenza Season Weekly Influenza Activity Report for Week Ending April 21, 2009. Available at: http://www.health.state.ny.us/diseases/communicable/influenza/surveillance/ Accessed on December 09, 2009
25. Hutchins SS, Fiscella K, Levine RS et al. Protection of Racial/Ethnic Minority Populations during an Influenza Pandemic. American Journal of Public Health. October 2009, Vol 99, S261-S270.
26. Matte T, Ellis JA, Bedell J et al. Obesity in the South Bronx: A look across generations. New York, NY: New York City Department of Health and Mental Hygiene, 2007.

Author Information

Raghu Loganathan, MD FCCP
Lincoln Medical & Mental Center

Yekaterina Sitnitskaya, MD
Lincoln Medical & Mental Center

Melissa Schori, MD MBA
Lincoln Medical & Mental Center

Aliya Saeed, MD
Lincoln Medical & Mental Center

Felix Rivera, MD
Lincoln Medical & Mental Center

Jorge Bastos, MD
Lincoln Medical & Mental Center

Yuly Carreras, MD
Lincoln Medical & Mental Center

Balavenkatesh Kanna, MD, MPH, FACP
Lincoln Medical & Mental Center

Your free access to ISPUB is funded by the following advertisements:

Advertisement

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy

Close

Enter the site

Login

Password

Remember me

Forgot password?

Login

SIGN IN AS A USER

Use your account on the social network Facebook, to create a profile on BusinessPress